Application of SNAP29 in identification of porcine blue ear disease resistance, breeding or preparation of disease control drugs

By promoting SNAP29 gene expression in pigs and improving its resistance to pig blue ear disease, the problem of poor vaccine effect and lack of resistance targets in the prior art is solved, and efficient pig blue ear disease resistance breeding and Prevention and control have significant economic benefits and clinical application value.

CN117925858BActive Publication Date: 2024-12-03SOUTH CHINA AGRICULTURAL UNIVERSITY
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202410236806.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-01
Publication Date
2024-12-03
Estimated Expiration
2044-03-01

AI Technical Summary

Technical Problem

Among the existing prevention and control measures for blue ear disease in pigs, the vaccine effect is not ideal and there is a lack of effective resistance targets, which limits the development of disease-resistant breeding and makes it difficult to effectively prevent and prevent the spread and epidemic of blue ear disease in pigs.

Method used

Using the SNAP29 gene or its protein as a genetically improved molecular target, by promoting its expression, it improves pig resistance to blue ear disease, and develops relevant expression level detection reagents and promoters for resistance identification and breeding, providing new treatment and prevention strategies.

Benefits of technology

By increasing the expression level of SNAP29 gene, it significantly improves the resistance of pigs to blue ear disease, providing efficient breeding programs and new treatment methods, with good economic benefits and clinical application value, and can be used as a means to identify pig susceptibility or resistance important reference standard for sex.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117925858B_ABST
    Figure CN117925858B_ABST
Patent Text Reader

Abstract

The present invention belongs to the field of biomedicine technology, and in particular, relates to the application of SNAP29 in the identification of resistance to blue ear disease in pigs, breeding, or the preparation of disease prevention and treatment drugs. The synaptosome-associated protein SNAP29 provided by the present invention can be used as a molecular target for genetic improvement. By promoting the expression of the gene, the resistance of pigs to blue ear disease can be improved and enhanced, and excellent gene resources and new solutions are provided for the efficient cultivation of varieties with strong resistance to blue ear disease in pigs. The cultivation of resistant pigs has good economic benefits, and also provides a new treatment approach for the prevention and control of blue ear disease in pigs, and has good clinical application value. In addition, the SNAP29 gene can be used as a detection target, and its expression level can be used as an important reference standard for identifying the susceptibility or resistance of pigs to blue ear virus, and has broad market prospects in the field of identification of resistance to blue ear disease in pigs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedical technology, and in particular to the application of SNAP29 in identification of porcine blue ear disease resistance, breeding or preparation of disease prevention and treatment drugs. Background Art

[0002] Porcine reproductive and respiratory syndrome (PRRS), also known as blue ear disease, is a viral infectious disease caused by porcine reproductive and respiratory syndrome virus (PRRSV), with sow abortion and respiratory disorders in pigs of all ages as the main symptoms. Sick pigs and carriers are the main sources of infection, and the main transmission routes are contact infection, airborne transmission, semen transmission and vertical placental transmission. Carrying pigs can carry the virus for a long time, and movement and transportation can also cause the spread of the disease, causing huge economic losses to the pig farming industry worldwide.

[0003] PRRSV can be divided into PRRSV-1 and PRRSV-2, also known as European and North American types, based on the difference in genome. Since PRRSV is an RNA virus, it is very easy to mutate and recombine, and its genetic evolution is extremely fast. New strains continue to emerge, making PRRS prevention and control even more difficult. The biggest difference between PRRSV and other viruses is that it mainly infects immune cells - porcine alveolar macrophages (PAMs), destroying the immune system, similar to HIV. The virus has the following characteristics: extremely easy to mutate and recombine, immunosuppressive, persistent infection, and resistance-dependent enhancement (ADE), making the prevention, control and elimination of the disease very difficult, and it has become one of the most difficult diseases to prevent and control in the pig industry.

[0004] The prevention and control of PRRSV mainly includes improving the biosafety system of pig farms, regular disinfection, maintaining environmental hygiene, vaccination, etc. However, based on the above characteristics of PRRSV, the commercial vaccines currently developed, including attenuated vaccines and inactivated vaccines, are not ideal and cannot effectively prevent the occurrence and spread of the disease. In addition, these vaccines have the following problems: slow production of neutralizing antibodies, poor cross-protection against heterologous strains, long duration of vaccine virus viremia, and recombination with field strains to produce recombinant viruses with stronger pathogenicity. Therefore, it is necessary to focus on the genetic perspective of the host (pig) to carry out research, cultivate new disease-resistant pig breeds (lines) through genetic improvement and disease-resistant breeding strategies, and improve the host's resistance to PRRS from a genetic level.

[0005] Biological breeding is the core of seed industry innovation. Based on the in-depth exploration of the relationship between the genetic background of germplasm resources and biological disease resistance traits, the discovery of resistance molecules is an important prerequisite and basis for implementing disease-resistant genetic improvement and cultivating new PRRS-resistant varieties. For example, Chinese patent CN106191320A discloses the application of HPSE genes in screening blue ear disease-resistant pigs, and cultivates new PRRS-resistant varieties (lines) through the discovery of PRRSV disease-resistant / susceptible genes and then through disease-resistant breeding. However, the current lack of PRRS resistance molecular targets has seriously restricted the development of pig disease-resistant breeding. Therefore, the development and search for new resistance / susceptibility genes can not only study the invasion and infection mechanisms of PRRSV, which is of great significance for the efficient cultivation and / or rapid screening of resistant varieties, but also provide new strategies for the treatment and prevention of PRRS. Summary of the invention

[0006] In view of the above technical problems in the prior art, the present invention provides the application of SNAP29 in the identification of resistance to blue ear disease in pigs, breeding or the preparation of disease prevention and control drugs. The SNAP29 gene or its protein provided by the present invention can be used as a molecular target for genetic improvement. By promoting the expression of the gene, the resistance of pigs to blue ear disease can be improved and enhanced, providing excellent gene resources and new solutions for the efficient breeding of varieties with strong resistance to blue ear disease in pigs, and the breeding of resistant pigs has good economic benefits. It also provides a new treatment approach for the prevention and control of blue ear disease in pigs, and has good clinical application value. In addition, the SNAP29 gene can be used as a detection target, and its expression level can be used as an important reference standard for identifying the susceptibility or resistance of pigs to blue ear virus, which has broad market prospects in the field of identification of resistance to blue ear disease in pigs.

[0007] The present invention is specifically implemented through the following technical solutions:

[0008] The first aspect of the present invention provides the use of SNAP29 or an expression level detection reagent thereof in the identification of resistance to blue ear disease in pigs.

[0009] Furthermore, the SNAP29 expression level detection reagent includes at least one of a SNAP29 protein antibody or a SNAP29 gene amplification primer pair.

[0010] Furthermore, the identification of porcine blue ear disease resistance includes the following steps: detecting the expression level of SNAP29 mRNA or SNAP29 protein, and judging the resistance of the individual pig to blue ear disease according to the expression level of the SNAP29 mRNA or the SNAP29 protein; the higher the expression level of the SNAP29 mRNA or the SNAP29 protein, the stronger the resistance of the individual pig to blue ear disease.

[0011] Furthermore, the method for detecting the expression level of SNAP29 mRNA includes a real-time fluorescence quantitative PCR method, and detecting the expression level of SNAP29 mRNA by the real-time fluorescence quantitative PCR method includes the following steps: extracting total RNA from the individual pig to be tested, and reverse transcribing it into cDNA; using the cDNA as a template, amplifying the internal reference gene and the SNAP29 gene by fluorescence quantitative PCR, calculating the relative expression level of the SNAP29 gene according to the fluorescence signals of the internal reference gene and the SNAP29 gene, and judging the resistance of the individual pig to blue ear disease according to the relative expression level of the SNAP29 gene; wherein the nucleotide sequence of the primer pair for amplifying the SNAP29 is shown in SEQ ID NO.1-2, and the nucleotide sequence of the primer pair for amplifying the internal reference gene is shown in SEQ ID NO.3-4.

[0012] Furthermore, methods for detecting SNAP29 protein include immunoblotting or immunofluorescence.

[0013] The second aspect of the present invention provides the use of SNAP29 or an expression promoter thereof in breeding for resistance to blue ear disease in pigs.

[0014] Furthermore, the SNAP29 expression promoter is selected from an expression activator, an enzyme activator, a compound promoter or a SNAP29 gene overexpression vector.

[0015] Furthermore, the breeding of porcine blue ear disease resistance includes the following steps: constructing a SNAP29 gene overexpression vector; introducing the SNAP29 gene overexpression vector into a pig, and cultivating and screening to obtain transgenic pig individuals with increased expression of the SNAP29 gene.

[0016] Furthermore, the method for constructing the SNAP29 gene overexpression vector includes: inserting the SNAP29 gene between the EcoRⅠ and XhoⅠ restriction sites of the mammalian expression vector pCMV to construct the SNAP29 gene overexpression vector.

[0017] The third aspect of the present invention provides the use of SNAP29 or its expression promoter in the preparation of a drug for preventing and treating porcine blue ear disease.

[0018] The advantages and positive effects of the present invention are:

[0019] The present invention has found that the expression level of the SNAP29 gene in the alveolar macrophages of pigs infected with the PRRSV pathogen is significantly reduced. The gene silencing can effectively promote the replication of PRRSV, while the overexpression significantly inhibits the replication of PRRSV. In addition, the group samples show that when the expression level of SNAP29 in individual pigs is high, they have strong resistance to PRRSV, and vice versa. It is the first time to confirm at the cellular level and the individual level that the expression level of the SNAP29 gene in pigs is significantly correlated with the infection and replication ability of PRRSV, and plays a key role in improving the resistance of pigs to blue ear disease. The SNAP29 gene or its protein provided by the present invention can be used as a molecular target for genetic improvement. By promoting the expression of the gene, the resistance of pigs to blue ear disease can be improved and enhanced, providing excellent gene resources and new solutions for the efficient breeding of varieties with strong resistance to blue ear disease in pigs. The breeding of resistant pigs has good economic benefits, and also provides a new treatment approach for the prevention and control of blue ear disease in pigs, and has good clinical application value. In addition, the SNAP29 gene can be used as a detection target, and its expression level can serve as an important reference standard for identifying the susceptibility or resistance of pigs to blue ear virus. It has broad market prospects in the field of blue ear disease resistance identification. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the following briefly introduces the drawings required for use in the description of the embodiments. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without creative work.

[0021] Figure 1 This is a graph showing the expression level of SNAP29 protein after PRRSV infection of PAMs cells at different time points and different MOIs in the embodiment of the present invention;

[0022] Figure 2 This is an immunoblot detection diagram of the expression levels of SNAP29 protein and PRRSV-N protein at different time points after PRRSV infection of SNAP29 gene knockdown PAMs cells in the embodiment of the present invention;

[0023] Figure 3 This is an immunofluorescence detection level diagram of PRRSV-N protein expression 24 hours after PRRSV infection of SNAP29 gene knockdown PAMs cells in the embodiment of the present invention;

[0024] Figure 4 This is an immunoblot detection diagram of the expression levels of SNAP29 protein and PRRSV-N protein at different time points after PRRSV infection of SNAP29 gene-overexpressing PAMs cells in an embodiment of the present invention;

[0025] Figure 5This is an immunofluorescence detection diagram of the expression level of PRRSV-N protein 24 hours after PRRSV infection of SNAP29 gene-overexpressing PAMs cells in an embodiment of the present invention. DETAILED DESCRIPTION

[0026] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with embodiments. The embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0027] Based on the information contained in the present invention, it is easy for those skilled in the art to make various changes to the precise description of the present invention without departing from the spirit and scope of the appended claims. It should be understood that the scope of the present invention is not limited to the defined processes, properties or components, because these embodiments and other descriptions are only for the purpose of illustrating specific aspects of the present invention. In fact, various changes that a person skilled in the art or related fields can obviously make to the embodiments of the present invention are covered within the scope of the appended claims.

[0028] In order to better understand the present invention but not to limit the scope of the present invention, all the numbers and other numerical values ​​used in the present invention to express the amount, percentage, etc. should be understood as modified by the word "approximately" in all cases. The term "approximately" has its usual meaning, which is used to indicate that a value includes the inherent variation of the error of the device or method used to determine the value, or contains a value close to the value, such as within 10% of the value (or range of values). Therefore, unless otherwise specified, the numerical parameters listed in the specification and the attached claims are approximate values, which may be changed according to the different ideal properties attempted to be obtained.

[0029] In addition, it should be noted that, unless otherwise defined, in the context of the present invention, the scientific and technical terms used should have the meanings commonly understood by those of ordinary skill in the art.

[0030] The meaning of the terms "include", "comprising", "containing", "having" and the like is non-restrictive, i.e., other steps and other ingredients that do not affect the result may be added. The term "and / or" should be regarded as a specific disclosure of each of the two specified features or components with or without the other. For example, "A and / or B" will be regarded as including the following situations: (i) A, (ii) B, and (iii) A and B.

[0031] The term "gene" is the entire nucleotide sequence required to produce a polypeptide chain or functional RNA. Therefore, gene expression includes transcription and the stable accumulation of coding RNA (mRNA) or functional RNA derived from the gene, and can also refer to the translation of mRNA into polypeptide or protein.

[0032] The term "messenger RNA (mRNA)" refers to RNA that can be translated into protein by an organism. The main sequence of mature mRNA is the coding sequence (CDS) of the gene, and there are non-coding regions on the upstream 5' side and the downstream 3' side.

[0033] The term "cDNA" refers to a DNA molecule that is reverse complementary to an RNA molecule (such as mRNA) after reverse transcription (first-strand cDNA) or a DNA molecule that has the same sequence as an RNA molecule except that U is replaced by T (second-strand cDNA). cDNA has no introns but only exon sequences.

[0034] The term "vector" refers to a self-replicating DNA molecule that transfers an exogenous target gene into a host organism, and is often in the form of a circular double-stranded DNA molecule. A vector containing a target gene is a recombinant vector. Typical vectors include plasmids, viruses, bacteriophages, cosmids, and minichromosomes. Plasmids are the most common form of vectors, and therefore, in the context of the present invention, plasmids and vectors can be used interchangeably.

[0035] The term "expression vector" allows an exogenous target gene inserted into the vector to be expressed in a host organism. When the expression vector is introduced into a suitable host organism, the inserted target gene (eg, the SNAP29 gene of the present invention) can be expressed.

[0036] The term "introduction" or "transfer" refers to the transfer of a target gene nucleic acid molecule (such as an overexpression vector containing the SNAP29 gene) into a host organism (pig), resulting in stable inheritance of the gene. The introduced nucleic acid molecule can be in the form of a plasmid retained in the host organism, or can be integrated into the genome of the host organism. Host organisms containing the introduced gene are called "transgenic" or "recombinant" or "transformed" organisms or "engineered" organisms. The introduction of expression vectors into host organisms can be carried out using conventional techniques well known to those skilled in the art.

[0037] The terms "overexpression", "overexpression" or "overexpression", "overexpression" and the like refer to the expression level of a gene exceeding the normal expression level. In a preferred embodiment, the expression level of a gene is at least 10%, 20%, 50%, 100% (2 times), 200% (3 times), 300% (4 times), or even more times higher than the expression level under normal conditions. In the present invention, overexpression or overexpression is relative to a wild-type pig individual.

[0038] Generally, the expression yield of a gene can be qualitatively or quantitatively measured by the level of mRNA obtained by transcription or the level of protein obtained by translation. tThe quantitative method is the most commonly used method to study the mRNA content of gene expression products. The quantitative results are based on the target gene and the internal reference gene C t The difference between the values ​​(ΔC t ) is used to reflect the relative quantification. The relative expression is calculated using formula 2 -ΔCt or 2 -ΔΔCt Calculation. The term “C t ” or “C t The “value” refers to the number of cycles experienced when the fluorescence signal in each reaction tube reaches the set threshold. The C value of each sample template t The value is linearly related to the logarithm of the starting copy number of the template. The more the starting copy number, the higher the C t The smaller the value, the higher the level of expression. Antibody-based immunological detection technology is the most commonly used method to study the protein content of gene expression products, such as enzyme linked immunosorbent assay (ELISA), immunofluorescence (IF), Western blot (WB) and flow cytometry (FC).

[0039] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, specific embodiments of the present invention are described in detail below with reference to the accompanying drawings.

[0040] In the preliminary experiments, the present invention found that the level of Synaptosome Associated Protein 29 (SNAP29) in pigs before and after infection with Porcine reproductive and respiratory syndrome virus (PRRSV) was significantly different through quantitative proteomics technology, indicating that it has the function of a biomarker and is related to PRRSV infection. The mRNA sequence of the protein is shown in NCBI accession number XM_003132993.4, and the protein sequence is shown in NCBI accession number XP_003133041.1. In order to further study the function of this gene, the expression level of SNAP29 gene after PRRSV infection in porcine alveolar macrophages (PAMs) was detected by Western blot (WB), and it was found that the SNAP29 mRNA level and protein level were significantly reduced, and the expression of SNAP29 gene further decreased with the extension of infection time; In addition, the PRRSV replication level was observed to increase in SNAP29 knockdown PAMs cells, while SNAP29 overexpression inhibited PRRSV replication; It was confirmed that the expression level of SNAP29 gene was closely related to PRRSV replication. At the same time, in vivo experimental studies showed that when the expression level of SNAP29 in pigs was high, they were resistant to PRRSV, and vice versa. These results show that the SNAP29 gene can be used as a detection target, and its expression level can be used as an important reference standard for identifying the susceptibility or resistance of pigs to blue ear virus. Moreover, this gene has the effect of improving and enhancing the resistance of pigs to PRRSV, and can also be used as a molecular target for PRRSV disease resistance breeding.

[0041] Based on the above findings, one embodiment of the present invention provides the use of SNAP29 or a reagent for detecting its expression level in identifying resistance to blue ear disease in pigs.

[0042] The present invention found in the cellular level challenge experiment and RNA interference experiment that the expression of SNAP29 gene is closely related to the in vivo replication of PRRSV. The reduction of its expression level will significantly promote PRRSV replication, while overexpression will inhibit PRRSV replication, suggesting that the SNAP29 gene is associated with the pig's ability to resist blue ear disease. Local Chinese pig breeds (Tongcheng pigs and Meishan pigs, resistant breeds, insensitive to PRRSV) and foreign pig breeds (Landrace pigs and Large White pigs, susceptible breeds, sensitive to PRRSV) were selected as research subjects, and PRRSV challenge experiments were carried out in pig groups. Then, according to the virus titer TCID in pig serum and lung and lymph node tissues, the serotype of the pigs was analyzed. 50The results showed that the expression level of SNAP29 was used to determine the difference in PRRSV infectivity among Tongcheng pigs, Meishan pigs, Landrace pigs and Large White pigs. The results showed that the expression level of SNAP29 was used to determine the susceptibility or resistance of pigs to blue ear virus, which was highly consistent with the actual phenotype of the pigs. It can effectively distinguish the phenotypic traits of the individual to be tested from the gene level, that is, the SNAP29 provided by the present invention can be used as a biological target, and the resistance of the individual pig to blue ear disease can be determined by detecting the expression level of the SNAP29 gene. When the expression level of SNAP29 is high, the pig is resistant to blue ear virus; otherwise, it is susceptible. The present invention converts the phenotypic identification of blue ear disease resistance to the detection of gene expression level, which is not limited by the sample size and breeding period, is conducive to the resistance screening of large-scale population samples, greatly saves the identification cost, improves the identification efficiency of blue ear disease resistant varieties, and then promotes the breeding process of excellent varieties, which has huge economic benefits for blue ear disease prevention and control and breeding.

[0043] In actual operation, the level of SNAP29 expression is based on the general level of expression of the gene or protein in pigs in the field. The level is relative, and the level of expression compared to the general level is used to assist in determining whether the pig is resistant to PRRSV or the degree of resistance. Moreover, the higher the SNAP29 expression level, the stronger the pig's resistance to blue ear disease, and vice versa.

[0044] Methods for detecting the expression of SNAP29 include detecting the mRNA or protein content of the SNAP29 gene, both of which can reflect the expression level of the gene. The detection of mRNA content can be achieved by real-time fluorescence quantitative PCR, and the detection reagents include primer pairs for specific amplification of the SNAP29 gene, amplification buffer, fluorescent colorimetric agents, etc.; the detection of protein content can be achieved by immunoblotting, immunofluorescence, etc., and the detection reagents include antibodies (primary antibodies) that specifically bind to the SNAP29 protein, buffers, and anti-antibodies (secondary antibodies) that bind to the SNAP29 protein antibodies.

[0045] Specifically, the SNAP29 mRNA expression level is detected by real-time fluorescence quantitative PCR, comprising the following steps:

[0046] Extracting total RNA from the individual pig to be tested, and reverse transcribing it into cDNA; using the cDNA as a template, amplifying the internal reference gene and the SNAP29 gene by fluorescent quantitative PCR, calculating the relative expression level of the SNAP29 gene according to the fluorescent signals of the internal reference gene and the SNAP29 gene, and judging the resistance of the individual pig to blue ear disease according to the relative expression level of the SNAP29 gene;

[0047] The nucleotide sequence of the primer pair for amplifying the SNAP29 is shown in SEQ ID NO.1-2, and the nucleotide sequence of the primer pair for amplifying the internal reference gene is shown in SEQ ID NO.3-4; the specific sequences are as follows:

[0048] SNAP29-F: 5′-CCCACCTGAACAGAATGGCA-3′ (see SEQ ID NO. 1);

[0049] SNAP29-R: 5′-TGGGGACAGGGTCTGTATCA-3′ (see SEQ ID NO. 2);

[0050] HPRT1-F: 5′-TGACAACAGCCTCAAGATCG-3′ (see SEQ ID NO. 3);

[0051] HPRT1-R: 5′-GTCTTCTGGGTGGCAGTGAT-3′ (see SEQ ID NO. 4).

[0052] According to the above statistical data of Tongcheng pigs, Meishan pigs, Landrace pigs, and Large White pigs, the standard is roughly as follows: when the expression level of SNAP29 is higher than 7.6±0.5×10 -2 When the expression level of SNAP29 was lower than 7.6±0.5×10 -2 When tested, the individual pigs are susceptible to PRRSV.

[0053] Another embodiment of the present invention provides the use of SNAP29 or its expression promoter in breeding for blue ear disease resistance in pigs.

[0054] The present invention found that by increasing the expression of the SNAP29 gene in pigs, the resistance of individual pigs to the PRRSV pathogen can be significantly improved and the replication level in the body can be reduced, indicating that the gene plays a key role in improving the resistance of pigs to blue ear disease, and provides excellent gene resources and new solutions for the efficient breeding of new blue ear disease-resistant germplasm. Taking the SNAP29 gene as a molecular target, by promoting the expression of the gene, it is possible to quickly breed high-resistance varieties of blue ear disease in pigs, which is conducive to improving the work efficiency of resistance breeding, and has broad application prospects and obvious economic benefits in the breeding field of PRRSV-resistant pigs.

[0055] Optionally, the SNAP29 expression promoter is used to increase or enhance the expression of the SNAP29 gene, and can be selected from an expression activator, an enzyme activator, a compound promoter or a SNAP29 gene overexpression vector.

[0056] Optionally, the breeding for blue ear disease resistance comprises the following steps:

[0057] Construct a SNAP29 gene overexpression vector; introduce the SNAP29 gene overexpression vector into a pig, and cultivate and screen to obtain transgenic pigs with increased SNAP29 gene expression. The transgenic pigs obtained thereby have an increased ability to resist infection by PRRSV pathogens, and greatly enhance their resistance to blue ear disease.

[0058] Optionally, the method for constructing the SNAP29 gene overexpression vector comprises: inserting the SNAP29 gene into the multiple cloning site (between EcoRⅠ and XhoⅠ restriction sites) of the mammalian expression vector pCMV to construct the SNAP29 gene overexpression vector.

[0059] The expression vector can be introduced into the host cell by conventional techniques well known to those skilled in the art, such as gene gun technique, microinjection, electroporation, vector transfection, and the like.

[0060] Based on the same inventive concept as above, another embodiment of the present invention provides the use of SNAP29 or its expression promoter in the preparation of drugs for preventing and treating porcine blue ear disease.

[0061] The present invention can reduce the replication level in the PRRSV pathogen by increasing the expression level of the SNAP29 gene in the pig, thus providing a new treatment approach for the prevention and control of blue ear disease in pigs and having good clinical application value.

[0062] Optionally, the SNAP29 expression promoter is selected from an expression activator, an enzyme activator, a compound promoter or a SNAP29 gene overexpression vector.

[0063] The present invention is further described below in conjunction with specific examples. The experimental methods in the following examples where specific conditions are not specified are usually performed under conventional conditions, such as the conditions described in the Molecular Cloning Laboratory Guide (Fourth Edition) published by Cold Spring Harbor Laboratory, or usually under the conditions recommended by the manufacturer.

[0064] Statistical analysis of the following examples: All experiments were repeated at least 3 times independently, and the results were expressed as mean values ​​and standard errors, and analyzed using one-way analysis of variance and T test. All statistical analyses used P<0.05 as the test standard for significant statistical differences, and the analysis software was SPSS18.0 and GraphPad Prism 9.0.

[0065] The porcine alveolar macrophages (PAMs) and PRRSV CH-1a\Li11 strains used in the following examples were all derived from and preserved in the laboratory of Chunhe Guo's research group at South China Agricultural University.

[0066] The mRNA sequence number of the synaptosome associated protein 29 (SNAP29) studied in the following examples is XM_003132993.4, and the protein sequence number is XP_003133041.1.

[0067] Example

[0068] 1. Detection of SNAP29 gene expression level in pig cells infected with PRRSV pathogen

[0069] Porcine alveolar macrophages (PAMs) were cultured in 1640 medium containing 10% fetal bovine serum, and PRRSV CH-1a strain was inoculated at different multiplicity of infection (MOI) (MOI=0, 0.1, 0.5, 1). Then, the cells were transferred to 1640 maintenance medium containing 2% fetal bovine serum for further culture. PAMs cells were collected after culture at 37°C for different time points (0, 12, 26, 36), and the SNAP29 mRNA and protein levels were detected by real-time fluorescence quantitative PCR (qRT-PCR) and protein immunoblot (Western blot, WB).

[0070] According to the porcine SNAP29 gene CDS sequence and the internal reference gene HPRT1, qRT-PCR quantitative primers were designed, and the nucleotide sequence is as follows:

[0071] SNAP29-F: 5′-CCCACCTGAACAGAATGGCA-3′ (see SEQ ID NO. 1);

[0072] SNAP29-R: 5′-TGGGGACAGGGTCTGTATCA-3′ (see SEQ ID NO. 2);

[0073] HPRT1-F: 5′-TGACAACAGCCTCAAGATCG-3′ (see SEQ ID NO. 3);

[0074] HPRT1-R: 5′-GTCTTCTGGGTGGCAGTGAT-3′ (see SEQ ID NO. 4).

[0075] The main steps of fluorescence quantitative PCR are as follows: first, the total RNA of PAMs cells was extracted by Trizol method, and RNA was used as a template to reverse transcribe and synthesize cDNA, and then fluorescence quantitative PCR was performed by SYBR Green method to detect the mRNA expression of SNAP29. The fluorescence quantitative PCR reaction system includes: SNAP29 upstream and downstream primers, cDNA template and polymerase mix (purchased from Nanjing Novozyme Biotechnology Co., Ltd., catalog number: Q711), and the reaction program is set as follows: 95℃300s, 40 cycles (95℃20s; 55℃20s; 72℃20s).

[0076] The main steps of Western blotting (WB) are as follows: first, PAMs cells are lysed with protein lysis buffer to prepare total protein samples, and the prepared total protein is quantified by the Bicinchoninic acid (BCA) method. Then, the protein samples are subjected to polyacrylamide electrophoresis to separate proteins according to molecular weight, and then transferred to PVDF membranes, and then the membranes are blocked. The target protein is specifically bound by the primary antibody / secondary antibody complex, and finally the protein expression of SNAP29 is detected by chemiluminescence. Among them, the SNAP29 antibody comes from Wuhan Mitaka Company, item number: 12704-1-AP, which is used to detect SNAP29 protein, the PRRSV-N protein antibody comes from South Korea MEDIAN Diagnostics Company, item number: JN0401, which is used to detect PRRSV pathogens, and the β-actin antibody comes from the United States Cell Signaling Technology Company, item number: 4967, as an internal reference, for relative quantification of SNAP29 protein and PRRSV-N protein.

[0077] The expression levels of SNAP29 protein and PRRSV-N protein in PAMs cells infected with PRRSV Li11 strain are shown in Figure 2. Figure 1 The results showed that the expression of SNAP29 protein in PAMs cells decreased significantly after virus infection, and the decrease in SNAP29 expression was more obvious as the infection time increased; as the virus infection dose increased, the expression of SNAP29 protein showed the same trend as above.

[0078] 2. Effect of SNAP29 gene knockdown on PRRSV replication in pig cells

[0079] According to the CDS sequence of the SNAP29 gene, SNAP29 interfering RNA (siRNA) was designed and synthesized, and a pair of control siRNA was designed as a negative control (Negative Control, NC), named si-SNAP29 and si-NC, respectively. Both consisted of a sense chain (sense) and an antisense chain (antisense), and were synthesized by Suzhou Hongxun Biotechnology Co., Ltd. The nucleotide sequence (5'-3') is as follows:

[0080] si-SNAP29-sense: GAAGAUUGACAGCAACCUAGAdTdT (see SEQ ID NO. 5);

[0081] si-SNAP29-antisense: UCUAGGUUGCUGUCAAUCUUCdTdT (see SEQ ID NO. 6);

[0082] si-NC-sense: UUCUCCGAACGUGUCACGUdTdT (see SEQ ID NO.7);

[0083] si-NC-antisense: ACGUGACACGUUCGGAGAAdTdT (see SEQ ID NO. 8).

[0084] Use of Lipofectamine TM PAMs cells were cultured in a six-well plate in 1640 medium containing 10% fetal bovine serum to a confluence of 60-80%, and the above-mentioned si-SNAP29, si-NC and Lipofectamine TM 2000 Reduced Serum Medium (purchased from Thermo Fisher Scientific, catalog number: 31985062) was used for dilution; after dilution, the mixture was mixed at a volume ratio of 1:1, incubated at room temperature for about 5 minutes, and then added to PAMs cells, cultured in a 37°C, 5% CO2 incubator for 6-8 hours, the supernatant was discarded, the cells were washed 1-2 times with PBS, and then cultured with complete medium for another 48 hours, the cells were collected, and the SNAP29 knockdown effect was detected by fluorescent quantitative PCR.

[0085] Another six-well plate was taken, and SNAP29 knockdown PAMs cells were selected and cultured for 48 h, then inoculated with PRRSV (MOI = 0.1), and cultured for another 36 h or 48 h. The cells were collected for protein immunoblotting experiments to verify the effect of SNAP29 knockdown on intracellular PRRSV proliferation.

[0086] Figure 2 The expression levels of SNAP29 protein and PRRSV-N protein after PRRSV infection of SNAP29 gene knockdown PAMs cells are shown, where + and - represent the addition and non-addition of the corresponding plasmid during transfection, Si-SNAP29 and si-NC represent SNAP29 siRNA and negative control siRNA, respectively, and CH-1a represents the PRRSV strain. It can be seen from the figure that compared with the control group (addition of si-NC treatment, SNAP gene expression is not affected), knocking down SNAP29 gene expression by siRNA significantly promoted PRRSV-N protein expression, indicating that the replication level of PRRSV strain increased.

[0087] Immunofluorescence experiments were further used for verification. Figure 3 The expression level of PRRSV-N protein before and after SNAP29 gene knockdown is shown, where green fluorescence indicates the expression of PRRSV-N protein and blue indicates the cell nucleus. The results show that after SNAP29 knockdown, the fluorescence intensity of PRRSV-N protein is significantly enhanced.

[0088] 3. Effect of SNAP29 gene overexpression on PRRSV replication in pig cells

[0089] First, a SNAP29 gene overexpression vector was constructed. The specific operations were as follows: EcoRⅠ and XhoⅠ enzymes were used to double-digest the pCMV empty vector and the PCR-amplified SNAP29 gene, respectively. After digestion, the digestion products were ligated with T4 DNA ligase to construct a SNAP29 gene overexpression vector named: pCMV-SNAP29, and the vector was identified by bacterial liquid PCR and sequenced to ensure that the plasmid was successfully constructed and the gene sequence had no mutations.

[0090] PAMs cells were cultured in 1640 medium containing 10% fetal bovine serum in two six-well plates until the confluence was 60-80%. In one six-well plate, Lipofectamine TM pCMV-SNAP29 and pCMV empty vector were transfected into PAMs cells with 3000 transfection reagent, respectively. After culturing in a 37°C, 5% CO2 incubator for 6-8h, the supernatant was discarded, the cells were washed 1-2 times with PBS, and cultured for another 24h with 1640 complete medium. The cells were collected to detect the overexpression effect of SNAP29.

[0091] After culturing for 24 hours, another six-well plate was inoculated with PRRSV and then cultured for another 36 hours or 48 hours. The cells were collected to detect the effect of SNAP29 overexpression on PRRSV proliferation.

[0092] Figure 4 and Figure 5 The expression levels of SNAP29 protein and PRRSV-N protein after PRRSV infection of SNAP29 gene overexpressing PAMs cells were detected by immunoblotting and immunofluorescence, respectively. Figure 4 + and - in the middle indicate that the corresponding plasmids were added or not added during transfection, pCMV-Myc and Myc-SNAP29 indicate the pCMV empty vector and the SNAP29 gene overexpression vector, respectively, and PRRSV indicates the PRRSV strain; Figure 5 The green fluorescence indicates the expression of PRRSV-N protein, and the blue indicates the cell nucleus. As can be seen from the figure, after the SNAP29 gene was overexpressed, PRRSV was inoculated and cultured for 36 and 48 hours, and the expression level of PRRSV-N protein was significantly reduced; the immunofluorescence experiment showed that the fluorescence intensity of PRRSV-N protein was significantly reduced, indicating that enhancing the expression level of the SNAP29 gene can inhibit the replication level of PRRSV in cells.

[0093] 4. Application of SNAP29 gene expression level in screening pigs resistant to blue ear disease

[0094] Local Chinese pig breeds (Tongcheng pig and Meishan pig) and foreign pig breeds (Landrace pig and Large White pig) were selected as research objects. Among them, Tongcheng pig and Meishan pig are insensitive to PRRSV, that is, they are resistant; while Landrace pig and Large White pig are sensitive to PRRSV, that is, they are susceptible.

[0095] 24 Tongcheng pigs, Meishan pigs, Landrace pigs, and Large White pigs aged 6 weeks with double negative antigens and antibodies to PRRSV, ASFV, PCV2, CSFV, etc. were selected, 8 pigs / group, and divided into the following 3 groups: PRRSV challenge group, DMEM inoculation group (negative control), and no treatment group (blank control). Blood was collected from each group 7 days before the challenge and on the 7th, 14th, 21st, 28th, and 35th days after the challenge. Euthanasia was performed on the 35th day, and blood, lung, spleen, lymph node, and tonsil tissues were collected after euthanasia. A portion of the serum collected from the blood was taken for half tissue culture infection dose (TCID 50 ) determination, and RNA was extracted from the remaining serum and lung, spleen, lymph node, and tonsil tissues for fluorescence quantitative PCR to detect the expression of SNAP29 gene and PRRSV N gene, and pathological sections of the lung, spleen, and lymph nodes were used for diagnosis.

[0096] According to TCID 50The susceptibility and resistance of local pigs (Tongcheng pigs and Meishan pigs) and foreign breeds (Landrace pigs and Large White pigs) to PRRSV were determined by the expression level of PRRSV N protein, lung and spleen virus load, and lung and lymph node tissue pathological sections. The relationship between the expression level of SNAP29 in pigs and the susceptibility and resistance of the above four breeds of pigs to PRRSV was studied.

[0097] Before the virus attack, blood was collected to detect the expression of the SNAP29 gene in pigs (pigs that were not attacked, that is, pigs not infected with PRRSV) (i.e., the background expression of the gene). The results showed that the expression of the SNAP29 gene in local pigs (Tongcheng pigs and Meishan pigs) was significantly higher than that in foreign breeds (Landrace pigs and Large White pigs). That is, based on the expression of the SNAP29 gene, it can be determined that Tongcheng pigs and Meishan pigs are not sensitive to PRRSV and have resistance, while Landrace pigs and Large White pigs are sensitive to PRRSV and have no resistance. This is consistent with the TCID 50 The actual phenotype determined by the results of SNAP29 gene expression, PRRSVN protein expression, lung and spleen virus load, and lung and lymph node tissue pathological sections was consistent, indicating that the level of SNAP29 gene expression is highly correlated with the susceptibility\resistance phenotype of pigs to PRRSV. Screening the resistance phenotype of individual pigs to PRRSV or identifying resistance based on the SNAP29 gene expression level has high accuracy.

[0098] Based on the research data of the present invention, the specific criteria for identifying pig susceptibility / resistance to PRRSV are: when the SNAP29 expression level is higher than 7.6±0.5×10 -2 (relative to the internal reference HPRT1 gene), pigs were resistant to PRRSV; the expression level was lower than 7.6±0.5×10 -2 (relative to the internal reference HPRT1 gene), pigs are susceptible to the virus.

[0099] In addition, blood was collected at different time points after virus inoculation to detect the expression level of SNAP29 gene in pigs again, showing that the expression level of SNAP29 in pigs was significantly reduced, which was consistent with the results at the cellular level (consistent in vivo and in vitro results), further confirming that PRRSV infection specifically induces changes in SNAP29 expression, and SNAP29 is closely related to the resistance or susceptibility of pigs to PRRSV.

[0100] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. Application of a SNAP29 gene expression level detection reagent in the preparation of a preparation for identifying resistance to blue ear disease in pigs, characterized in that: The mRNA sequence number of the SNAP29 gene is XM_003132993.

4. The identification of porcine blue ear disease resistance includes the following steps: The expression level of SNAP29 gene was detected, and the resistance of the individual pig to blue ear disease was judged according to the expression level of SNAP29 gene; when the expression level of SNAP29 gene relative to the internal reference gene HPRT1 was higher than 7.6±0.5×10 -2 When the expression level of SNAP29 gene relative to the internal reference gene HPRT1 was lower than 7.6±0.5×10 -2 At this time, pigs are susceptible to blue ear disease.

2. The use of the SNAP29 gene expression level detection reagent according to claim 1 in the preparation of a preparation for identifying resistance to blue ear disease in pigs, characterized in that: The detection reagent for the expression level of the SNAP29 gene includes a SNAP29 gene amplification primer pair.

3. Use of the SNAP29 gene expression level detection reagent according to claim 1 in the preparation of a preparation for identifying resistance to blue ear disease in pigs, characterized in that: The method for detecting the expression level of the SNAP29 gene includes a real-time fluorescence quantitative PCR method. Detecting the expression level of the SNAP29 gene by the real-time fluorescence quantitative PCR method includes the following steps: Extract total RNA from individual pigs to be tested and reverse transcribe it into cDNA; Using the cDNA as a template, amplifying an internal reference gene and a SNAP29 gene by fluorescent quantitative PCR, calculating the relative expression of the SNAP29 gene according to the fluorescent signals of the internal reference gene and the SNAP29 gene, and judging the resistance of the individual pig to blue ear disease according to the relative expression of the SNAP29 gene, wherein the internal reference gene is the HPRT1 gene; The nucleotide sequence of the primer pair for amplifying the SNAP29 gene is shown in SEQ ID NO.1-2, and the nucleotide sequence of the primer pair for amplifying the internal reference gene is shown in SEQ ID NO.3-4.

4. Use of the SNAP29 gene or its expression promoter in the preparation of a drug for the prevention and treatment of porcine blue ear disease, characterized in that: The mRNA sequence number of the SNAP29 gene is XM_003132993.4, and the SNAP29 gene expression promoter is selected from a SNAP29 gene overexpression vector.

5. Use of the SNAP29 gene or its expression promoter according to claim 4 in the preparation of a drug for the prevention and treatment of porcine reproductive and respiratory syndrome, characterized in that: The method for constructing the SNAP29 gene overexpression vector comprises: The SNAP29 gene is inserted between the EcoRⅠ and XhoⅠ restriction sites of the mammalian expression vector pCMV to construct the SNAP29 gene overexpression vector.

Citation Information

Patent Citations

  • Application of HPSE gene in screening of pigs with resistance to reproductive and respiratory syndrome

    CN106191320A

  • Application of TREM-2 gene in identification of susceptibility of pigs to reproductive and respiratory syndrome virus

    CN106244682A

  • Method for screening anti-porcine reproductive and respiratory syndrome pigs based on expression quantity of SIRT2

    CN110804662A

  • Application of SNAPIN protein and coding gene thereof in anti-influenza virus

    CN117562981A